BALTIMORE--(BUSINESS WIRE)--Infinity Bio, a technology company known for its innovative antibody reactome profiling service, will host an open house event at its state-of-the-art laboratory at 6200 Seaforth Street in Baltimore on July 23, 2024. This event is designed to give members of the local scientific and biotech community an exclusive look at the research and technologies that are driving developments in immunology..

巴尔的摩--（商业新闻短讯）--Infinity Bio是一家以创新抗体反应组分析服务而闻名的技术公司，将于2024年7月23日在巴尔的摩西沃斯街6200号的最先进实验室举办一次开放式活动。本次活动旨在让当地科学和生物技术界的成员独家了解推动免疫学发展的研究和技术。。

Infinity Bio, founded in 2023, utilizes its proprietary MIPSA technology to perform advanced antibody reactivity profiling, providing deep insights that are crucial for developing next-generation therapeutics and diagnostics. The company’s core technology comprehensively measures the antibody reactome, revealing the targets of individual immune responses against all known human viruses, human proteins (autoimmunity), and allergen proteins.

Infinity Bio成立于2023年，利用其专有的MIPSA技术进行先进的抗体反应性分析，提供对开发下一代治疗和诊断至关重要的深刻见解。该公司的核心技术全面测量抗体反应组，揭示了针对所有已知人类病毒，人类蛋白质（自身免疫）和过敏原蛋白质的个体免疫反应的目标。

Developed at Johns Hopkins University in Dr. H. Benjamin Larman's Laboratory of Precision Immunology, Infinity Bio’s assay builds off decades of work in genomics, proteomics, immunology, and bioinformatics, ensuring best-in-class turnaround times and cost efficiency. Larman also serves as Infinity Bio’s Chief Science Officer..

Infinity Bio的检测方法是在约翰·霍普金斯大学（Johns Hopkins University）的H.Benjamin Larman博士的精密免疫学实验室开发的，它建立在基因组学、蛋白质组学、免疫学和生物信息学领域数十年的工作基础上，确保了最佳的周转时间和成本效益。拉曼还担任Infinity Bio的首席科学官。。

The event will include live demonstrations of sample processing through their state-of-the-art automation system, Q&A sessions with Infinity Bio’s researchers, and a preview of informatics reporting. Attendees will also have the chance to network with other professionals in the field.

该活动将包括通过他们最先进的自动化系统进行样品处理的现场演示，与Infinity Bio的研究人员进行问答，以及信息学报告的预览。与会者还将有机会与该领域的其他专业人士建立联系。

“We are eager to showcase our laboratory, commitment to quality, and our team,” says Joy M. Nassif, CEO of Infinity Bio. “Our team is dedicated to the pursuit of scientific excellence and customer delight, and we believe that transparency and collaboration are key to driving innovation.”

“我们渴望展示我们的实验室、对质量的承诺和我们的团队，”Infinity Bio首席执行官Joy M.Nassif说。“我们的团队致力于追求科学卓越和客户愉悦，我们相信透明度和合作是推动创新的关键。”

Larman states: “The open house will be a unique opportunity for researchers in academia and biotech to learn about our industry leading antibody reactome profiling services, and to see for themselves how Infinity Bio can transform their immunology research.”

拉曼说：“开放日将是学术界和生物技术研究人员了解我们业界领先的抗体反应组分析服务的独特机会，并亲自了解Infinity Bio如何改变他们的免疫学研究。”

To register for the open house, please visit https://www.infinitybio.com/open-house-rsvp.

要注册开放日，请访问https://www.infinitybio.com/open-house-rsvp.

ABOUT INFINITY BIO

关于INFINITY BIO

Infinity Bio, Inc. is a technology company that provides detailed insights into the immune system using its proprietary antibody profiling platform. The company’s core technology comprehensively measures the antibody reactome, revealing the targets of individual immune responses against all known human viruses, human proteins (autoimmunity), and allergen proteins.

Infinity Bio，Inc.是一家技术公司，使用其专有的抗体分析平台提供对免疫系统的详细见解。该公司的核心技术全面测量抗体反应组，揭示了针对所有已知人类病毒，人类蛋白质（自身免疫）和过敏原蛋白质的个体免疫反应的目标。

Infinity's assay, MIPSA, was developed at Johns Hopkins University in Dr. H. Benjamin Larman's Laboratory of Precision Immunology. It builds off of decades of work in the fields of genomics, proteomics, immunology, and bioinformatics. Our assay was engineered to enable best-in-class turnaround times and core to our values are quality and customer delight..

Infinity的检测方法MIPSA是在约翰霍普金斯大学的H.Benjamin Larman博士的精确免疫学实验室开发的。它建立在基因组学，蛋白质组学，免疫学和生物信息学领域数十年的工作基础上。我们的检测方法旨在实现一流的周转时间，我们价值观的核心是质量和客户满意度。。